Article Details

AstraZeneca's Combination Inhaler Shines In Phase 3 Asthma Trial - Benzinga

Retrieved on: 2022-05-16 17:42:24

Tags for this article:

Click the tags to see associated articles and topics

AstraZeneca's Combination Inhaler Shines In Phase 3 Asthma Trial - Benzinga. View article details on hiswai:

Excerpt

AstraZeneca Plc. AZN+2.75%+ Free Alerts · posted full results from the positive MANDALA Phase 3 trial of PT027, an albuterol/budesonide fixed-dose ...

Article found on: www.benzinga.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up